Yuhas E M, Lofton F T, Rosenberg H A, Mayron D, Baldinus J G
Am J Hosp Pharm. 1981 Dec;38(12):1919-22.
The stability of cimetidine hydrochloride mixed in intravenous solutions individually with 37 additives was investigated. Recommended doses of cimetidine hydrochloride injection and the other additives were diluted aseptically in varying concentrations in compatible intravenous solutions. The admixtures were stored at room temperature for 24 hours. Initial and 24-hour samples were evaluated visually on the basis of color, clarity, and pH. Cimetidine content was determined with a high-pressure liquid chromatographic procedure. The following drugs formed a precipitate with some dilutions of cimetidine hydrochloride injection in i.v. solutions: amphotericin B, cefamandole nafate, cefazolin sodium, and cephalothin sodium. The combination of cimetidine hydrochloride (300 mg) and cephalothin sodium (100 mg) resulted in a cimetidine concentration that was 77% of theory. Cimetidine hydrochloride injection was visually and chemically stable in the other admixtures examined. The results of this investigation suggest that incompatibility may be expected when cimetidine hydrochloride is combined with some antibiotics, and cimetidine incompatibilities may be concentration dependent.
研究了盐酸西咪替丁分别与37种添加剂混合于静脉输液中的稳定性。将推荐剂量的盐酸西咪替丁注射液及其他添加剂无菌稀释成不同浓度的相容静脉输液。混合液在室温下储存24小时。根据颜色、澄清度和pH值对初始和24小时的样品进行外观评估。采用高压液相色谱法测定西咪替丁含量。以下药物与盐酸西咪替丁注射液在静脉输液中的某些稀释液形成沉淀:两性霉素B、头孢孟多酯钠、头孢唑林钠和头孢噻吩钠。盐酸西咪替丁(300mg)与头孢噻吩钠(100mg)的组合导致西咪替丁浓度为理论值的77%。在其他所检测的混合液中,盐酸西咪替丁注射液在外观和化学性质上是稳定的。本研究结果表明,盐酸西咪替丁与某些抗生素合用时可能会出现配伍禁忌,且西咪替丁的配伍禁忌可能与浓度有关。